An Interim Perspective on the Removal of Encainide and Flecainide from the Cardiac Arrhythmia Suppression Trial

Fox EJ . Dear doctor letter. Evansville, IN: Bristol Laboratories, April 25, 1989.

Eagleton G . Dear doctor letter. St. Paul, MN: 3M Riker, April 26, 1989.

Myerburg RJ Castellanos A . Cardiac arrest and sudden cardiac death. In: Braunwald E , ed. Heart disease: A textbook of cardiovascular medicine. 3rd ed. Philadelphia: WB Saunders, 1988: 742–77.

The Cardiac Arrhythmia Pilot Study (CAPS) investigators. Effects of encainide, flecainide, imipramine, and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS. Am J Cardiol 1988; 61: 501–9.

The Cardiac Arrhythmia Pilot Study (CAPS) investigators. Recruitment and baseline description of patients in the Cardiac Arrhythmia Pilot Study. Am J Cardiol 1988; 61: 704–13.

Greene HL Richardson DW Barker AH Classification of deaths after myocardial infarction as arrhythmic or non-arrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989; 63: 1–6.

Greene HL Richardson DW Hallstrom AP Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989; 63: 393–8.

Bigger JT . Methodology for clinical trials with antiarrhythmic drugs to prevent cardiac death: US experience. Cardiology 1987; 74 (suppl 2):40–56.

Stanton MS Prystowsky EN Fineberg NS Miles WM Zipes DP Heger JJ . Incidence of ventricular tachycardia or ventricular fibrillation as proarrhythmic effects during treatment of ventricular arrhythmia (abstract). J Am Coll Cardiol 1987; 9: 245A.

Morganroth J Anderson JL Gentzkow GD . Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide. J Am Coll Cardiol 1986; 8: 607–15.

Soyka LF . Safety of encainide for the treatment of ventricular arrhythmias. Am J Cardiol 1986; 58: 96C–103C.

Morganroth J . Risk factors for the development of proarrhythmic events. Am J Cardiol 1987; 59: 32E–37E.

Anderson JL Pritchett ELC , eds. International symposium on supraventricular arrhythmias: Focus on flecainide. Am J Cardiol 1988; 62: 1D–67D.

Naccarelli GV Wellens HJJ , eds. A symposium: The use of encainide in supraventricular tachycardias. Am J Cardiol 1988; 62: 1L–84L.